PARIS, FRANCE, July 8, 2024 – AGS Therapeutics, a preclinical-stage biotech company pioneering microalgae extracellular vesicles (MEV) as a new, universal delivery system, announced today the appointment of Dr Renee T. Williams as an Independent Director to its board of directors, bringing the total number of board members to seven. To know more
